Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 5/20 | 0.70 |
| ▸ | RAB9A | P51151 | 3/20 | 0.62 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.54 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.54 |
| ▸ | CA1 | P00915 | 2/20 | 0.51 |
| ▸ | CA2 | P00918 | 2/20 | 0.51 |
| ▸ | NPC1 | O15118 | 3/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.49 |
| ▸ | CA12 | O43570 | 1/20 | 0.49 |
| ▸ | CA7 | P43166 | 1/20 | 0.49 |
| ▸ | CA9 | Q16790 | 1/20 | 0.49 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.49 |
| ▸ | MEN1 | O00255 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.48 |
| ▸ | GAA | P10253 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | TP53 | P04637 | 1/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL927098 | 0.92 | MAPT (0.72) | MAPTRAB9AL3MBTL1TDP1CA1 | |
| SCHEMBL28751206 | 0.86 | MAPT (0.49) | MAPTRAB9AL3MBTL1GAA | |
| SCHEMBL13008762 | 0.86 | MAPT (0.72) | MAPTRAB9AL3MBTL1TDP1CA1 | |
| SCHEMBL1983431 | 0.85 | TDP1 (0.57) | MAPTRAB9AL3MBTL1TDP1CA1 | |
| SCHEMBL20649443 | 0.85 | MAPT (0.49) | MAPTRAB9AL3MBTL1CA1CA2 | |
| SCHEMBL2469151 | 0.85 | MAPT (0.89) | MAPTRAB9AL3MBTL1TDP1CA1 | |
| SCHEMBL18406249 | 0.84 | L3MBTL1 (0.71) | MAPTRAB9AL3MBTL1KDM4EMEN1 | |
| SCHEMBL21448021 | 0.84 | CA12 (0.53) | MAPTRAB9AL3MBTL1CA1CA2 | |
| SCHEMBL14990879 | 0.84 | MAPT (0.48) | MAPTRAB9AL3MBTL1TDP1NPC1 | |
| SCHEMBL5054312 | 0.83 | MAPT (0.85) | MAPTRAB9AL3MBTL1TDP1CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8865273-B2 | Photoalignment compound, photoalignment composition, display substrate having an alignment layer, and method for manufacturing the display substrate | SAMSUNG DISPLAY CO., LTD. (KR) | 2014-10-21 | — | — | US | disclosed |
| US-20120301628-A1 | PHOTOALIGNMENT COMPOUND, PHOTOALIGNMENT COMPOSITION, DISPLAY SUBSTRATE HAVING AN ALIGNMENT LAYER, AND METHOD FOR MANUFACTURING THE DISPLAY SUBSTRATE | JO SUNG-CHAN (KR) | 2012-11-29 | — | — | US | disclosed |
| US-8257801-B2 | Photoalignment compound, photoalignment composition, display substrate having an alignment layer, and method for manufacturing the display substrate | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2012-09-04 | — | — | US | disclosed |
| US-20100141862-A1 | PHOTOALIGNMENT COMPOUND, PHOTOALIGNMENT COMPOSITION, DISPLAY SUBSTRATE HAVING AN ALIGNMENT LAYER, AND METHOD FOR MANUFACTURING THE DISPLAY SUBSTRATE | SAMSUNG DISPLAY CO., LTD. (KR) | 2010-06-10 | — | — | US | disclosed |
| US-20040242572-A1 | New carboxamide compounds having melanin concentrating hormone antagonistic activity, pharmaceutical preparations comprising these compounds and process for their manufacture | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2004-12-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100141862-A1 | PHOTOALIGNMENT COMPOUND, PHOTOALIGNMENT COMPOSITION, DISPLAY SUBSTRATE HAVING AN ALIGNMENT LAYER, AND METHOD FOR MANUFACTURING THE DISPLAY SUBSTRATE | PKN3, MARK3, MCHR1 | MAPT 2220/4885RAB9A 2820/4885L3MBTL1 1837/4885 |
| US-20040242572-A1 | New carboxamide compounds having melanin concentrating hormone antagonistic activity, pharmaceutical preparations comprising these compounds and process for their manufacture | MCHR2, MCHR1, NPY1R | MAPT 4481/4885RAB9A 2725/4885L3MBTL1 3619/4885 |
| US-20120301628-A1 | PHOTOALIGNMENT COMPOUND, PHOTOALIGNMENT COMPOSITION, DISPLAY SUBSTRATE HAVING AN ALIGNMENT LAYER, AND METHOD FOR MANUFACTURING THE DISPLAY SUBSTRATE | PKN3, MARK3, MCHR1 | MAPT 2242/4885RAB9A 2816/4885L3MBTL1 1822/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.